Epworth Healthcare

East Melbourne, Victoria 3002

3 studies enrolling now · 10 studies all time

What they study most

Advanced MTAP-null Solid Tumors, Advanced Solid Tumors, Biochemically Recurrent Prostate Cancer, Breast Cancer, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Colorectal Cancer, Follicular Lymphoma, Indolent Lymphoma, MALT Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma

Studies at this site

• Study of INCA036978 in Participants With Myeloproliferative Neoplasms — Recruiting now
• Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy — Recruiting now
• Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma — Recruiting now
• A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling
• A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101) — Running, not enrolling
• Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant — Running, not enrolling
• Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. — Completed
• A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors — Completed
• A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma — Completed
• PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies — Status unconfirmed